相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of apolipoprotein C3 with insulin resistance and coronary artery calcium in patients with type 1 diabetes
Teresa Buckner et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2021)
Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation
Stephen Zewinger et al.
NATURE IMMUNOLOGY (2020)
A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia
Maureen Sampson et al.
JAMA CARDIOLOGY (2020)
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Jan Boren et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
Monika A. Niewczas et al.
NATURE MEDICINE (2019)
Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D
Arpita Basu et al.
JOURNAL OF LIPID RESEARCH (2019)
Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes
Jenny E. Kanter et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Very-Low-Density Lipoprotein- Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III
Raimund Pechlaner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk The EPIC-Norfolk Prospective Population Study
Julian C. van Capelleveen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia
Maaike Kockx et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
Michael A. Gimbrone et al.
CIRCULATION RESEARCH (2016)
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
Andres Digenio et al.
DIABETES CARE (2016)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Different Lipid Variables Predict Incident Coronary Artery Disease in Patients With Type 1 Diabetes With or Without Diabetic Nephropathy: The FinnDiane Study
Nina Tolonen et al.
DIABETES CARE (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects
Maria F. Lopes-Virella et al.
DIABETES CARE (2013)
Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
Anette Varbo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Circulating TNF Receptors 1 and 2 Predict Stage 3 CKD in Type 1 Diabetes
Tomohito Gohda et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
Sandrine Caron et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Endothelial Dysfunction in Diabetes The role of reparatory mechanisms
Angelo Avogaro et al.
DIABETES CARE (2011)
Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study
Valma Harjutsalo et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
Per-Henrik Groop et al.
DIABETES (2009)
Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes
N. Tolonen et al.
DIABETOLOGIA (2009)
Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: The Hoorn Study
Peter G. Scheffer et al.
CLINICAL CHEMISTRY (2008)
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
Akio Kawakami et al.
CIRCULATION (2006)
A long-term study of dyslipidemia and dyslipoproteinemia in stable post-renal transplant patients
Elzbieta Kimak et al.
RENAL FAILURE (2006)
Metabolic syndrome in type 1 diabetes -: Association with diabetic nephropathy and glycemic control (the FinnDiane study)
LM Thorn et al.
DIABETES CARE (2005)
Apolipoprotein C-III protein concentrations and gene polymorphisms in type I diabetes - Associations with microvascular disease complications in the DCCT/EDIC cohort
RL Klein et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2005)
Apolipoprotein CIII promotes Ca2+-dependent β cell death in type 1 diabetes
L Juntti-Berggren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study
MB Mattock et al.
DIABETIC MEDICINE (2001)
分享论文
